| Time |
Course |
Title |
| 6:45–8:00 am |
|
Continental Breakfast |
| 8:00–9:00 am |
PLS-1 |
Plenary Session: Our Duty to Relieve Pain |
| 9:05–10:05 am |
SIS-01 |
Special Interest Session TBA |
| 10:05–10:30 am |
|
Break |
| 10:30–11:30 am |
BHV-03 |
Group Therapy for Pain Control |
| MDL-01 |
Guidelines Development and Implementation |
| NRO-01 |
Peripheral Pain Mechanisms: Transduction to Transmission |
| PEF-01 |
Learning Theories |
| RHM-03 |
Fibromyalgia: What It Is, Isn’t, and What We Can Do
About It |
| 11:30 am–12:30 pm |
BHV-04 |
Individual Therapy for Pain Control |
| MDL-02 |
Legal Resolutions: What Can Courts Do For Us? |
| NRO-02 |
Central Pain Mechanisms: Modulation, Perception, and
Analgesic Pathways |
| PEF-02 |
Understanding Bloom’s Taxonomy & Establishing Core
Objectives |
| RHM-04 |
Fibromyalgia: Hands-On Manual Tender Point Examination |
| 12:30–2:30 pm |
|
Lunch and Exhibits |
| 2:30–3:30 pm |
BHV-05 |
Beyond Operant and Respondent Conditioning |
| INT-01 |
Interventions to Consider When Managing Complex
Regional Pain Syndrome |
| MDL-03 |
Pain Policy: Living and Treating Pain in the USA |
| PHM-04 |
Long-Term Care Pharmacotherapy: The Role of the
Consulting Pharmacist |
| RHM-05 |
What Is Myofacial Pain? |
| 3:30–4:30 pm |
BHV-06 |
Working With Families to Change Patients |
| INT-02 |
Neurolytics for Spinal Pain: Pulsed Radiofrequency,
Neurolysis, and Ziconotide |
| MDL-04 |
Issues in Using Evidenced-Based Guidelines |
| PHM-05 |
Antipsychotic Medications for Pain: Is There a Role? |
| RHM-06 |
Myofacial Pain “Hands On” Workshop |
| 6:45–8:15 pm |
|
Welcome Reception, Exhibits, and Keynote Speaker |
